HIKMA Pharmaceuticals announced on Tuesday that the U.S. FDA approved its Abbreviated New Drug Application (ANDA 218728), signaling a positive pipelin...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Somerset Therapeutics has received FDA approval for the intravenous formulation of sugammadex, the antidote to rocuronium bromide, marking a pivotal e...
Hikma Pharmaceuticals USA Inc. announced on Friday the approval of sugammaDEX sodium for the intravenous treatment of hyperkalemia, securing a key FDA...
TEVA PHARMS USA INC announced the FDA approval of its ANDA application 214126, clearing the way for the launch of the generic version of the Blockbust...
Baxter Healthcare Corporation received marketing authorization for a generic Intramuscular Diazepam solution on July 28, 2026, introducing additional ...
MANKIND PHARMA announced FDA approval for ANDA214230 on July 28, 2026, a decision expected to strategically expand its product portfolio and drive rev...
VIATRIS SPECIALTY receives FDA approval for the New Drug Application 219990 on July 28, 2026, with significant market implications expected to drive p...
PAI HOLDINGS announced the approval of its ANDA by the FDA for a new generic drug on July 28, setting the stage for imminent market entry and potentia...
Sun Pharmaceutical Industries announced Monday that the FDA has approved the ANDA for sugammadex sodium, expanding a strategic market opportunity with...
Institutional holdings report (13F-HR) filed by TMT General Partner Ltd....
Institutional holdings report (13F-HR) filed by ProCore Advisors, LLC....
Institutional holdings report (13F-HR) filed by TAIYO LIFE INSURANCE CO....
Institutional holdings report (13F-HR) filed by Latitude Advisors, LLC....
Institutional holdings report (13F-HR) filed by Strategic Financial Concepts, LLC....
Institutional holdings report (13F-HR) filed by Sellwood Investment Partners LLC....
Institutional holdings report (13F-HR) filed by ACUTE INVESTMENT ADVISORY, LLC....
Institutional holdings report (13F-HR) filed by NOVUS ADVISORS, LLC....
Institutional holdings report (13F-HR) filed by Kure Advisory, LLC....
After a favorable court ruling on specific causation, Johnson & Johnson is proposing a resolution to roughly 76,000 ovarian talc claims conditioned on...
Keen Vision Acquisition Corp. filed an amended and restated charter as a merger sponsor. Market implications include clarified corporate governance fo...